Morgan Stanley, MSCI, Raymond James Financial, and Benzinga are involved in the process of receiving and issuing analyst ratings and research reports on company stocks.
2 reports, 2 independent
Updated Jul 21
Gone quiet
- Reports
- 2
- Developments
- 5
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley, MSCI, Raymond James Financial, and Benzinga are involved in the process of receiving and issuing analyst ratings and research reports on company stocks.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Morgan Stanley and Raymond James Financial issued conflicting analyst ratings (raise/downgrade) for V2X, Inc. on August 18, 2026.Sub-event
- Morgan Stanley raised price targets and ratings for Ultragenyx Pharmaceutical.Sub-event
- Morgan Stanley raised its price forecast for Palo Alto Networks, while Benzinga assigned a Momentum score to the company.Sub-event
- Jefferies Financial Group began coverage of MSCI stock, while Raymond James raised its target price and Morgan Stanley reaffirmed its rating.Sub-event
Financial firms are issuing research reports and analyst ratings on company stock.1 source
Keep exploring
The entities involved
-
Morgan Stanley
U.S. investment bank
-
MSCI
American financial service provider
-
Raymond James Financial
American Investment Bank and Financial Services Firm
-
Benzinga
American news channel
Related events
- Analyst firms provided ratings and price targets for Merit Medical Systems on August 28, 2026, involving Raymond James Financial and Bank of America Corp.
- Analyst rating targets are increasing across the market, with data aggregated by various financial firms including FactSet and MarketBeat.
- Analyst reports are affecting stock ratings and targets for companies including Shake Shack, Morgan Stanley, and Citigroup.
- Analysts have raised price targets and ratings for Elevance Health, involving Bank of America, Raymond James Financial, and TD Cowen.
- Analyst reports affect stock price targets for companies involving Morgan Stanley, Lockheed Martin, and Citigroup.